戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  were identified with a primary diagnosis of pancreatic neoplasm.
2 ma of the pancreas is the most common benign pancreatic neoplasm.
3 eatic ductal adenocarcinoma (PDAC), a deadly pancreatic neoplasm.
4 erstand the relevance of these signatures in pancreatic neoplasms.
5 s per year, and they account for 1-2% of all pancreatic neoplasms.
6   Two patients with choledochoceles (7%) had pancreatic neoplasms.
7 copic techniques for diagnosing and treating pancreatic neoplasms.
8 cience and clinical advances in the field of pancreatic neoplasms.
9 ly in the ladder of oncogenesis, as in human pancreatic neoplasms.
10 local ablative treatment of solid and cystic pancreatic neoplasms.
11 to achieve better outcomes for patients with pancreatic neoplasms.
12               These data suggest that cystic pancreatic neoplasms 1) occur in 0.7% of patients, 2) in
13  benign pancreatic neoplasm (34%), malignant pancreatic neoplasm (31%), other neoplasm (15%), chronic
14 imary DP, the indications for DP were benign pancreatic neoplasm (34%), malignant pancreatic neoplasm
15 organ will certainly shape the management of pancreatic neoplasm and holds the promise of improved ou
16 s on this organ is changing the treatment of pancreatic neoplasms and holds the promise of improved o
17 efine the risk of premalignant and malignant pancreatic neoplasms and potential benefits and limitati
18 EST PRACTICE ADVICE 8: The target detectable pancreatic neoplasms are resectable stage I pancreatic d
19              Acinar cell carcinomas are rare pancreatic neoplasms associated with postresection survi
20  Expression of large T antigen is highest in pancreatic neoplasms, but is also detectable in the norm
21    Screening can detect curable, noninvasive pancreatic neoplasms, but the optimal imaging approach i
22     Only few case reports of mucinous cystic pancreatic neoplasm containing an undifferentiated carci
23                             The treatment of pancreatic neoplasm continues to change and improve as m
24                          Pancreatic and peri-pancreatic neoplasms encompass a variety of histotypes c
25  standard resection for benign and low-grade pancreatic neoplasms, has been described in mainly small
26                                              Pancreatic neoplasms have high morbidity and dismal prog
27                         Human PDAC cells and pancreatic neoplasms in mice contain morphologically and
28  APC/beta-catenin pathway in other nonductal pancreatic neoplasms including pancreatoblastomas and ac
29 influence the development and progression of pancreatic neoplasms initiated by an oncogenic allele of
30 gration of molecular radionuclide imaging of pancreatic neoplasms into mainstream clinical practice.
31 accepted and agreed on terminology for solid pancreatic neoplasms, is needed.
32 id-pseudopapillary tumors (SPTs) are unusual pancreatic neoplasms of low malignant potential that mos
33 events or severe hypoglycemia, pancreatitis, pancreatic neoplasms, or allergic reactions than was pla
34 hat have affected the study and treatment of pancreatic neoplasms over the past year.
35 s of ACCs overlap with those of another rare pancreatic neoplasm, pancreatoblastoma.
36                             The treatment of pancreatic neoplasms remains a major challenge for physi
37 These compound mutant mice developed a novel pancreatic neoplasm, serous cystadenoma (SCA), presentin
38              Twenty-two patients with cystic pancreatic neoplasms that were confirmed at surgical res
39 red in locally advanced or centrally located pancreatic neoplasms to achieve complete tumor clearance
40                            In resected human pancreatic neoplasms, we find that foci of phospho-ERK-p
41                                              Pancreatic neoplasms were induced in rats by implantatio
42  ductal adenocarcinomas, and 6 miscellaneous pancreatic neoplasms) were microdissected from 29 formal
43 Primary tumors, usually lung, colorectal, or pancreatic neoplasms, were identified in 135 patients (2
44 or the separate clonal evolution of multiple pancreatic neoplasms within individual patients.